Follitropin alfa biosimilar - Fertility Biotech

Drug Profile

Follitropin alfa biosimilar - Fertility Biotech

Alternative Names: AFOLIA; Bemfola; Bemfola Pen; Follitropin alfa solution pre-filled pen; Follitropin alpha biosimilar - Fertility Biotech; Follitropin-alfa; r-hFSH biosimilar - Fertility Biotech; recombinant human follicle-stimulating hormone - Fertility Biotech

Latest Information Update: 30 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator FINOX
  • Developer Fertility Biotech; FINOX
  • Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins; Recombinant proteins
  • Mechanism of Action Chorionic gonadotropin stimulants; Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Female infertility; Male infertility

Most Recent Events

  • 30 Nov 2015 Launched for Male infertility in European Union (SC)
  • 30 Nov 2015 Registered for Male infertility in European Union (SC)
  • 30 Nov 2015 Preregistration for Female infertility in Australia (SC) before 30 November 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top